Exparel 266 MG/20 ML vial 20ML

Ended Awarded Last action

Contract number
SPE2DR26FBPPV
Awardee
Awarding agency
Obligated
$12,136

Award facts

Contract value 100% obligated
$12,136.06 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, for $12,136.06 for EXPAREL 266 mg/20 ml vials, with an ultimate completion date of March 10, 2026.

DMS Pharmaceutical Group Inc. is a woman-owned small business. The delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide.

Place of performance is Park Ridge, Illinois.

Quick answers

Who was awarded contract SPE2DR26FBPPV?

SPE2DR26FBPPV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 17, 2026.

How much is contract SPE2DR26FBPPV worth?

The government has obligated $12,136 on SPE2DR26FBPPV.

Is contract SPE2DR26FBPPV an order under another contract?

Yes. SPE2DR26FBPPV is a delivery order under SPE2DR25D9309, an indefinite delivery contract.

Was contract SPE2DR26FBPPV competed?

The extent of competition for SPE2DR26FBPPV was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award